One can see a few parallels to A2-73 and a very stark contrast as well. A2-73 has a lot of quality of life, improvements in daily living reports as well as some quite remarkable improvements ....painter, pianist, golfer, now Can take public transport and Not get lost, resolution of ALZ inducted insomnia, resolution of irritability, increased sociability and many others.
Maybe if there were more emphasis on improving the quality of life rather than blindly focusing on some biomarkers that may not be correlative in improvements in the first place, as in What happened to abeta/tau, then maybe Drug Companies would do a better job of finding drugs to improve quality of life in ALZ patients.
Dr. MacFarlane said something relative to this in his interview.